Stemline Therapeutics to Present at the 13th Annual Needham

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Stemline Therapeutics to Present at the 13th Annual Needham Healthcare Conference

NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 13th Annual Needham Healthcare Conference on Tuesday, April 8, 2014 at 12:10 PM ET. The conference will be held at the Westin Grand Central Hotel in New York, NY. A live webcast of the presentation can be viewed on the Company's website at www.stemline.com .

About Stemline Therapeutics

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk in a variety of cancer types. Stemline is currently developing two clinical-stage product candidates, SL-401 and SL-701. SL-401 is a targeted therapy directed to the interleukin-3 receptor (IL-3R). SL-401 has demonstrated single-agent activity, including durable complete responses (CRs), in a Phase 1/2 trial in several indications including blastic plasmacytoid dendritic cell neoplasm (BPDCN) and relapsed or refractory acute myeloid leukemia (AML). SL-401 is being advanced into later stage programs in BPDCN and other rare IL-3R+ malignancies, as well as additional hematologic cancers including AML and myeloma. SL-701 is a subcutaneously-administered therapeutic cancer vaccine comprised of multiple synthetic peptides. The vaccine, now being developed by Stemline as SL-701, has demonstrated single-agent activity, including durable CRs and partial responses (PRs), in Phase 1/2 trials in advanced adult and pediatric brain cancers. SL-701 is being advanced into later stage trials of adults with glioblastoma multiforme (GBM) at first recurrence, and children with brainstem and non-brainstem glioma. For more information about Stemline Therapeutics, visit www.stemline.com .

Forward-Looking Statements

Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The factors that could cause our actual results to differ materially are identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof.

Investor Relations Stemline Therapeutics, Inc. 750 Lexington Avenue 11th Floor New York, NY 10022 Tel: 646-502-2307 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 497

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 414

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 239

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 618

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 536

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 404

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 379

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

iLearningEngines Takes Action Amid Revenue Scrutiny Concerns

Updated Category News Views 109

Overview of the Situation Surrounding iLearningEngines Recently, iLearningEngines, Inc. (NASDAQ: AILE) has unexpectedly found itself under scrutiny. The company announced the formation of a special committee to investigate serious allegations that have come to light, particularly from Hindenburg Research. This committee's goal is to conduct a thorough investigation into...

Continue Reading
Convertus Secures $135M for York Biofuel Project

Updated Category News Views 46

Convertus Flexes Financial Muscle in Sustainable Energy Let's yank the spotlight onto a pretty significant move in the renewable energy sector—Convertus Group has snagged a hefty $135 million in project financing for a new biofuel facility in Ontario's York Region. Yeah, we're talking big numbers and big implications here as Canada takes a shot at pushing its green...

Continue Reading
Market Dynamics of the Nasdaq 100 Amid Changing Liquidity Conditions

Updated Category News Views 435

Understanding Nasdaq 100's Market Trends The recent downturn in the Nasdaq 100 has raised significant concerns among investors. This decline has almost completely negated the gains that followed the US presidential election, showcasing a shift in market sentiment. The persistent rise in the 10-year US Treasury yield has rendered US equities less attractive, leading many...

Continue Reading
Revolutionizing Smartphones with Easily Replaceable Parts

Updated Category News Views 221

Revolutionizing Smartphone Repairs In today's fast-paced technological world, smartphones have become an integral part of our lives. The constant reliance on these devices makes it frustrating when a simple issue arises, often leading users to replace the entire phone. However, one inventive solution is gearing up to change that narrative altogether. The Vision Behind the...

Continue Reading
Aker Solutions Reports Strong Performance in Q3 2025

Updated Category News Views 254

Aker Solutions Reports Strong Performance in Q3 2025 Aker Solutions has recently announced its third-quarter results for 2025, showcasing remarkable growth and solid financial margins. The company continues to enhance its project portfolio and anticipates that its revenues for the year will surpass NOK 60 billion. Financial Highlights of Q3 2025 For the third quarter,...

Continue Reading